Fatty acids and Alzheimer’s Disease: Evidence on Cognition and Cortical β-amyloid from Secondary Analyses of the Multidomain Alzheimer Preventive Trial - 21/11/24
Doi : 10.14283/jpad.2018.7
Claudie Hooper 1, ⁎ 
, B. Vellas 1, 2
, B. Vellas 1, 2MAPT/DSA study group
1 Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France
2 MR1027, Université de Toulouse, UPS, INSERM, Toulouse, France
a +33 (5) 61 77 64 25, +33 (5) 61 77 64 75 +33 (5) 61 77 64 25 +33 (5) 61 77 64 75
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Mappa
© 2018
THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 5 - N° 3
P. 168-170 - Luglio 2018 Ritorno al numero
Articolo precedente
- WHO Guidelines on Community-Level Interventions to Manage Declines in Intrinsic Capacity: The Road to Prevention Cognitive Decline in Older Age?
- B. Vellas, D. Scrase, G.A. Rosenberg, S. Andrieu, I. Araujo de Carvalho, L.T. Middleton
- What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force
- P.S. Aisen, E. Siemers, D. Michelson, S. Salloway, C. Sampaio, M.C. Carrillo, R. Sperling, R. Doody, P. Scheltens, R. Bateman, M. Weiner, B. Vellas, EU/US/CTAD Task Force members
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.